493 related articles for article (PubMed ID: 35167909)
21. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
Rizzo A; Brandi G
Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
[TBL] [Abstract][Full Text] [Related]
22. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology.
Kaneko R; Sato Y; Kobayashi Y
J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416
[TBL] [Abstract][Full Text] [Related]
23. The reality of cholangiocarcinoma in India- real world data from a tertiary referral centre.
Patkar S; Gupta V; Khobragade K; Goel M
HPB (Oxford); 2022 Sep; 24(9):1511-1518. PubMed ID: 35379594
[TBL] [Abstract][Full Text] [Related]
24. Cholangiocarcinoma in patients with primary sclerosing cholangitis.
Fung BM; Tabibian JH
Curr Opin Gastroenterol; 2020 Mar; 36(2):77-84. PubMed ID: 31850928
[TBL] [Abstract][Full Text] [Related]
25. Cholangiocarcinoma.
Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
[TBL] [Abstract][Full Text] [Related]
26. Cholangiocarcinoma.
Khan AS; Dageforde LA
Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
[TBL] [Abstract][Full Text] [Related]
27. [Management of hilar cholangiocarcinoma].
Muscari F
J Chir (Paris); 2007; 144(5):385-92. PubMed ID: 18065892
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of cholangiocarcinoma.
Bergquist A; von Seth E
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
[TBL] [Abstract][Full Text] [Related]
29. The treatment of cholangiocarcinoma: a hepatologist's perspective.
Qureshi K; Jesudoss R; Al-Osaimi AM
Curr Gastroenterol Rep; 2014 Oct; 16(10):412. PubMed ID: 25183579
[TBL] [Abstract][Full Text] [Related]
30. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
31. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
32. Gallbladder cancer mimicking perihilar cholangiocarcinoma-considerable rate of postoperative reclassification with implications for prognosis.
Nooijen LE; Gustafsson-Liljefors M; Erdmann JI; D'Souza MA; Gilg S; Villard C; Jansson H
World J Surg Oncol; 2023 Sep; 21(1):286. PubMed ID: 37697321
[TBL] [Abstract][Full Text] [Related]
33. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
35. Management of perihilar cholangiocarcinoma in the era of multimodal therapy.
Valero V; Cosgrove D; Herman JM; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):481-95. PubMed ID: 22928900
[TBL] [Abstract][Full Text] [Related]
36. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center study.
Zhang C; You X; Zhang Q; Wang D
Invest New Drugs; 2024 Feb; 42(1):24-34. PubMed ID: 37975978
[TBL] [Abstract][Full Text] [Related]
38. Cholangiocellular Carcinoma.
Vogel A; Saborowski A
Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
[TBL] [Abstract][Full Text] [Related]
39. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
40. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
